Publications by authors named "K C Lindfield"

Claim this Profile
S
Safety of daptomycin in patients completing more than 14 days of therapy: results from the Cubicin® Outcomes Registry and experience.
Shruta Rege, John Mohr, Kenneth C Lamp, Min Yoon, Kimberly C Lindfield

Int J Antimicrob Agents· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
George Sakoulas, Jack Brown, Kenneth C Lamp, Lawrence V Friedrich, Kimberly C Lindfield

Clin Ther· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.
D E Katz, K C Lindfield, J N Steenbergen, D P Benziger, K J Blackerby

Int J Clin Pract· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry.
W J Martone, K C Lindfield, D E Katz

Int J Clin Pract· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of daptomycin with two recombinant thromboplastin reagents leads to falsely prolonged patient prothrombin time/International Normalized Ratio results.
Peggy S Webster, Frederick B Oleson, David L Paterson, Charles F Arkin, Alexandra Mangili, Kimberly C Lindfield

Blood Coagul Fibrinolysis· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis